chartexchange

KRYS
Krystal Biotech, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:55 PM EST
315.27USD+5.602%(+16.72)345,900
After-hoursNov 18, 2026 4:26:30 PM EST
315.34USD+0.021%(+0.07)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Krish S. Krishnan
HQ
Pittsburgh, PA, USA
Previous Close
$298.55
Beta
0.75
52-Week High
$382.54 2026-06-30
52-Week Low
$202.99 2025-11-18
SMA 50
$324.50
SMA 200
$309.88
Avg. Vol 10D
233,770
Avg. Vol 30D
291,783
Avg. Vol 90D
353,063
Relative Vol
1.19
23.66M
0.2800%
3,350
KRYS Profile

krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that "nature operates in the shortest way possible". (aristotle)

KRYS Performance
PeriodPriceDateChangeBeta
1W308.812026-11-11+2.06%1.070
1M320.252026-10-19-1.58%0.733
3M332.822026-08-18-5.30%0.817
6M291.752026-05-18+8.03%0.469
1Y204.742025-11-18+53.94%0.750
2Y175.642024-11-18+79.45%—
5Y50.112021-11-18+528.98%1.232
KRYS Stock Summary

Krystal Biotech, Inc. Common Stock (NASDAQ:KRYS) stock price today is $315.18, and today's volume is 345,900. KRYS is up 5.570% today. The 30 day average volume is 291,783. KRYS market cap is $9.34B with 29.63M shares outstanding.